Related Experiment Videos
Influenza vaccine effectiveness in patients with chronic obstructive pulmonary disease: a cohort study emulating a
Simon Galmiche1, Sophie Dell'Aniello2, Linda Lévesque3
1Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Objectives:
Many observational studies of influenza vaccine effectiveness have faced issues of residual confounding and immortal time bias. We aimed to assess the effectiveness in people with COPD, using a novel study design to address these methodological challenges.
Methods:
We conducted a cohort study emulating a randomized trial within the primary care practices contributing data to England's Clinical Practice Research Datalink. We identified the base cohort of patients diagnosed with COPD, aged 40 years and above, initiating an inhaled treatment. Those vaccinated between September 2014 and March 2020 were matched 1:1 with unvaccinated people on the week of vaccination and the time-conditional propensity score. The primary outcome was hospitalized influenza during epidemic periods. Secondary outcomes included a composite of acute exacerbations of COPD, pneumonia, and hospitalized influenza. Urinary tract infections during epidemic periods and the composite outcome outside of influenza seasons (May - August) were used to detect residual confounding.
Results:
The emulated trial included 56,652 matched pairs of vaccinated and unvaccinated patients with COPD. The hazard ratio for hospitalized influenza was 0.61 (95% confidence interval 0.48-0.77) during epidemic periods. The HR for the composite secondary outcome was 0.89 (95% CI 0.87-0.92) during epidemic periods and 0.99 (95% CI 0.94-1.04) outside influenza seasons. The HR for urinary tract infection was 0.83 (95% CI 0.77-0.90). Results were consistent in several sensitivity analyses, such as when excluding patients consulting for reasons likely precluding vaccination.
Conclusion:
Influenza vaccine was associated with a reduced risk of hospitalized influenza in patients with COPD, but a reduced risk of urinary tract infection suggests important residual confounding. While this study design addresses immortal time bias, methodological improvements are needed to better address residual confounding in cohort studies of the influenza vaccine. In the meantime, negative control outcomes should be assessed during influenza epidemics to better detect residual confounding.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation